Microalgae cultivation for antibiotic oxytetracycline wastewater treatment

Microalgae-based technology provides a potential approach to biologically treating oxytetracycline (OTC) wastewater due to its environmental friendliness, low cost, and high efficiency. However, the OTC degradation and transformation characteristics by microalgae are still unclear and need further exploration. This study used microalgae Chlorella sorokiniana MB-1 for OTC wastewater treatment. The OTC with an initial concentration less than 50 mg L-1 promoted microalgae growth, while OTC with a concentration higher than 100 mg L-1 inhibited microalgae growth significantly. More than 99% OTC was removed with the biomass productivity up to 1.8 g L-1 when treated OTC with 10 mg L-1 initial concentration for 7 days. Chlorophyll and total sugar contents decreased, while protein and lipid contents increased compared to the control without OTC. The malondialdehyde content firstly reduced but subsequently enhanced when increased OTC concentration, while superoxide dismutase content gradually enhanced, manifesting that traces of OTC stimulate microalgae antioxidant capacity, while the increasing OTC caused further oxidative damage to microalgae cells. The removal pathways of OTC mainly include photolysis (75.8%), biodegradation (17.8%), biosorption (3.6%), and hydrolysis (2.7%). Overall, removing OTC by microalgae was confirmed to be an excellent technology for treating antibiotics wastewater whilst accumulating microalgae biomass.